CRYO-CELL INTL INC (CCEL) Fundamental Analysis & Valuation

NYSEARCA:CCEL • US2288951088

Current stock price

3.7 USD
-0.03 (-0.8%)
Last:

This CCEL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. CCEL Profitability Analysis

1.1 Basic Checks

  • In the past year CCEL has reported negative net income.
  • CCEL had a positive operating cash flow in the past year.
  • In multiple years CCEL reported negative net income over the last 5 years.
  • Of the past 5 years CCEL 4 years had a positive operating cash flow.
CCEL Yearly Net Income VS EBIT VS OCF VS FCFCCEL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -0.75%, CCEL is in line with its industry, outperforming 43.00% of the companies in the same industry.
  • CCEL has a better Return On Invested Capital (7.64%) than 71.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CCEL is in line with the industry average of 8.74%.
  • The last Return On Invested Capital (7.64%) for CCEL is above the 3 year average (7.61%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.75%
ROE N/A
ROIC 7.64%
ROA(3y)-3.55%
ROA(5y)0.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.61%
ROIC(5y)11.38%
CCEL Yearly ROA, ROE, ROICCCEL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1.3 Margins

  • In the last couple of years the Profit Margin of CCEL has declined.
  • CCEL has a better Operating Margin (13.63%) than 85.00% of its industry peers.
  • CCEL's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 77.07%, CCEL belongs to the top of the industry, outperforming 92.00% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CCEL has grown nicely.
Industry RankSector Rank
OM 13.63%
PM (TTM) N/A
GM 77.07%
OM growth 3Y-12.93%
OM growth 5Y-12.62%
PM growth 3Y-44.14%
PM growth 5Y-29.46%
GM growth 3Y2.95%
GM growth 5Y1.88%
CCEL Yearly Profit, Operating, Gross MarginsCCEL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. CCEL Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CCEL is destroying value.
  • CCEL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CCEL Yearly Shares OutstandingCCEL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CCEL Yearly Total Debt VS Total AssetsCCEL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of 0.06, we must say that CCEL is in the distress zone and has some risk of bankruptcy.
  • CCEL's Altman-Z score of 0.06 is on the low side compared to the rest of the industry. CCEL is outperformed by 75.00% of its industry peers.
  • The Debt to FCF ratio of CCEL is 1.36, which is an excellent value as it means it would take CCEL, only 1.36 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.36, CCEL belongs to the top of the industry, outperforming 82.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 1.36
Altman-Z 0.06
ROIC/WACC0.66
WACC11.56%
CCEL Yearly LT Debt VS Equity VS FCFCCEL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

2.3 Liquidity

  • CCEL has a Current Ratio of 0.63. This is a bad value and indicates that CCEL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of CCEL (0.63) is worse than 86.00% of its industry peers.
  • CCEL has a Quick Ratio of 0.63. This is a bad value and indicates that CCEL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.60, CCEL is not doing good in the industry: 83.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.63
Quick Ratio 0.6
CCEL Yearly Current Assets VS Current LiabilitesCCEL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. CCEL Growth Analysis

3.1 Past

  • CCEL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -616.67%.
EPS 1Y (TTM)-616.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-113.64%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.26%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-38.19%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.55%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CCEL Yearly Revenue VS EstimatesCCEL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
CCEL Yearly EPS VS EstimatesCCEL Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 -0.5 -1

More info and screens

Find the best growth stocksShow best growing peers

2

4. CCEL Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CCEL. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CCEL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CCEL Price Earnings VS Forward Price EarningsCCEL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CCEL indicates a rather cheap valuation: CCEL is cheaper than 91.00% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, CCEL is valued cheaply inside the industry as 95.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 4.82
EV/EBITDA 6.07
CCEL Per share dataCCEL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. CCEL Dividend Analysis

5.1 Amount

  • CCEL has a Yearly Dividend Yield of 12.08%, which is a nice return.
  • CCEL's Dividend Yield is rather good when compared to the industry average which is at 0.50. CCEL pays more dividend than 100.00% of the companies in the same industry.
  • CCEL's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 12.08%

5.2 History

  • CCEL has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
CCEL Yearly Dividends per shareCCEL Yearly Dividends per shareYearly Dividends per share 2022 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • CCEL has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-1109.12%
EPS Next 2YN/A
EPS Next 3YN/A
CCEL Yearly Income VS Free CF VS DividendCCEL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

More info and screens

Find the best dividend stocksShow peers with best dividend

CCEL Fundamentals: All Metrics, Ratios and Statistics

CRYO-CELL INTL INC

NYSEARCA:CCEL (4/9/2026, 8:16:05 PM)

3.7

-0.03 (-0.8%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-27
Earnings (Next)04-22
Inst Owners7.12%
Inst Owner Change0%
Ins Owners41.98%
Ins Owner Change0.79%
Market Cap29.82M
Revenue(TTM)N/A
Net Income(TTM)-473.50K
Analysts43.33
Price Target8.67 (134.32%)
Short Float %0.13%
Short Ratio0.4
Dividend
Industry RankSector Rank
Dividend Yield 12.08%
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP-1109.12%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)227.45%
Min EPS beat(2)178.43%
Max EPS beat(2)276.47%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.61%
Min Revenue beat(2)-3.88%
Max Revenue beat(2)-3.33%
Revenue beat(4)0
Avg Revenue beat(4)-2.41%
Min Revenue beat(4)-3.88%
Max Revenue beat(4)-0.9%
Revenue beat(8)0
Avg Revenue beat(8)-2.16%
Revenue beat(12)2
Avg Revenue beat(12)-0.97%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.94
P/FCF 4.82
P/OCF 4.69
P/B N/A
P/tB N/A
EV/EBITDA 6.07
EPS(TTM)-0.31
EYN/A
EPS(NY)-0.43
Fwd EYN/A
FCF(TTM)0.77
FCFY20.73%
OCF(TTM)0.79
OCFY21.31%
SpS3.94
BVpS-1.84
TBVpS-2.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.75%
ROE N/A
ROCE 9.68%
ROIC 7.64%
ROICexc 8.24%
ROICexgc 8.84%
OM 13.63%
PM (TTM) N/A
GM 77.07%
FCFM 19.48%
ROA(3y)-3.55%
ROA(5y)0.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.61%
ROIC(5y)11.38%
ROICexc(3y)7.98%
ROICexc(5y)14.72%
ROICexgc(3y)8.63%
ROICexgc(5y)16.85%
ROCE(3y)9.64%
ROCE(5y)14.41%
ROICexgc growth 3Y-17.95%
ROICexgc growth 5Y-25.17%
ROICexc growth 3Y-16.74%
ROICexc growth 5Y-23.68%
OM growth 3Y-12.93%
OM growth 5Y-12.62%
PM growth 3Y-44.14%
PM growth 5Y-29.46%
GM growth 3Y2.95%
GM growth 5Y1.88%
F-Score7
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 1.36
Debt/EBITDA 1.54
Cap/Depr 17.31%
Cap/Sales 0.54%
Interest Coverage 2.13
Cash Conversion 119.5%
Profit Quality N/A
Current Ratio 0.63
Quick Ratio 0.6
Altman-Z 0.06
F-Score7
WACC11.56%
ROIC/WACC0.66
Cap/Depr(3y)548.95%
Cap/Depr(5y)370.25%
Cap/Sales(3y)23.15%
Cap/Sales(5y)15.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-616.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-113.64%
EPS Next Y-38.19%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.26%
Revenue Next Year-3.55%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.52%
EBIT growth 3Y-9.92%
EBIT growth 5Y-12.52%
EBIT Next Year43.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y112.76%
FCF growth 3Y-15.98%
FCF growth 5Y-8.62%
OCF growth 1Y-20.62%
OCF growth 3Y-8.81%
OCF growth 5Y-1.01%

CRYO-CELL INTL INC / CCEL Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CRYO-CELL INTL INC?

ChartMill assigns a fundamental rating of 3 / 10 to CCEL.


What is the valuation status of CRYO-CELL INTL INC (CCEL) stock?

ChartMill assigns a valuation rating of 2 / 10 to CRYO-CELL INTL INC (CCEL). This can be considered as Overvalued.


What is the profitability of CCEL stock?

CRYO-CELL INTL INC (CCEL) has a profitability rating of 5 / 10.


Can you provide the financial health for CCEL stock?

The financial health rating of CRYO-CELL INTL INC (CCEL) is 3 / 10.